342 related articles for article (PubMed ID: 25775187)
1. Can antineutrophil cytoplasmic antibody levels be used to inform treatment of pauci-immune vasculitis?
Fussner LA; Specks U
Curr Opin Rheumatol; 2015 May; 27(3):231-40. PubMed ID: 25775187
[TBL] [Abstract][Full Text] [Related]
2. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
[TBL] [Abstract][Full Text] [Related]
3. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.
Shah S; Havill J; Rahman MH; Geetha D
Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939
[TBL] [Abstract][Full Text] [Related]
4. Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
Shuai ZW; Lv YF; Zhang MM; Hu ZY
Genet Mol Res; 2015 May; 14(2):5296-303. PubMed ID: 26125725
[TBL] [Abstract][Full Text] [Related]
5. Pauci-immune necrotizing glomerulonephritis.
Rutgers A; Sanders JS; Stegeman CA; Kallenberg CG
Rheum Dis Clin North Am; 2010 Aug; 36(3):559-72. PubMed ID: 20688250
[TBL] [Abstract][Full Text] [Related]
6. Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre.
Pullerits R; Ljevak M; Vikgren J; Bokarewa M
Scand J Immunol; 2012 Oct; 76(4):411-20. PubMed ID: 22823472
[TBL] [Abstract][Full Text] [Related]
7. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?
Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M
Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology and Laboratory Findings in Patients with ANCA-Associated Vasculitis].
Wada T
Rinsho Byori; 2015 Oct; 63(10):1213-9. PubMed ID: 26897859
[TBL] [Abstract][Full Text] [Related]
9. Controversies in ANCA testing.
Specks U
Cleve Clin J Med; 2012 Nov; 79 Suppl 3():S7-11. PubMed ID: 23203649
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
[TBL] [Abstract][Full Text] [Related]
11. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis.
Cong M; Chen M; Zhang JJ; Hu Z; Zhao MH
Nephrology (Carlton); 2008 Jun; 13(3):228-34. PubMed ID: 18315705
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
[TBL] [Abstract][Full Text] [Related]
13. [Rapidly progressive ANCA-negative glomerulonephritis in the course of pauci immune microscopic vasculitis with hemolytic anemia probable in the course of Wilson's disease].
Wieczorek-Surdacka E; Kaczmarczyk I; Jasik P; Przepiórkowska-Hoyer B; Sułowicz W
Przegl Lek; 2011; 68(2):123-5. PubMed ID: 21751523
[TBL] [Abstract][Full Text] [Related]
14. Otolaryngologic manifestations of antineutrophil cytoplasmic antibody-associated vasculitis.
Nakamaru Y; Takagi D; Oridate N; Homma A; Fukuda S
Otolaryngol Head Neck Surg; 2012 Jan; 146(1):119-21. PubMed ID: 21987646
[TBL] [Abstract][Full Text] [Related]
15. Complement in antineutrophil cytoplasmic antibody-associated vasculitis.
Yuan J; Chen M; Zhao MH
Clin Exp Nephrol; 2013 Oct; 17(5):642-645. PubMed ID: 23180036
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
Csernok E; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil Cytoplasmic Antibodies Testing and Interpretation.
Allard-Chamard H; Liang P
Clin Lab Med; 2019 Dec; 39(4):539-552. PubMed ID: 31668268
[TBL] [Abstract][Full Text] [Related]
18. Pauci-immune crescentic glomerulonephritis associated with ANCA of IgA class.
Bollée G; Noël LH; Suarez F; Royal V; Gilardin L; de Serre NP; El-Ghoul B; Lesavre P; Alyanakian MA; Fakhouri F
Am J Kidney Dis; 2009 Jun; 53(6):1063-7. PubMed ID: 19084310
[TBL] [Abstract][Full Text] [Related]
19. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
20. B cell epitope specificity in ANCA-associated vasculitis: does it matter?
van der Geld YM; Stegeman CA; Kallenberg CG
Clin Exp Immunol; 2004 Sep; 137(3):451-9. PubMed ID: 15320893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
